Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 10, 2021

SELL
$2.08 - $3.6 $4,368 - $7,560
-2,100 Closed
0 $0
Q1 2021

Apr 26, 2021

BUY
$9.26 - $14.36 $18,520 - $28,720
2,000 Added 2000.0%
2,100 $21,000
Q4 2019

Feb 11, 2020

SELL
$5.12 - $12.22 $537 - $1,283
-105 Reduced 51.22%
100 $1,000
Q3 2019

Nov 07, 2019

SELL
$5.24 - $15.89 $10,453 - $31,700
-1,995 Reduced 90.68%
205 $1,000
Q2 2019

Dec 03, 2019

BUY
$5.1 - $11.89 $11,220 - $26,158
2,200 New
2,200 $26,000
Q2 2019

Jul 30, 2019

SELL
$5.1 - $11.89 $11,220 - $26,158
-2,200 Closed
0 $0
Q1 2019

Dec 03, 2019

BUY
$3.03 - $6.02 $6,666 - $13,243
2,200 New
2,200 $12,000
Q1 2019

May 10, 2019

SELL
$3.03 - $6.02 $6,666 - $13,243
-2,200 Closed
0 $0
Q4 2018

Dec 03, 2019

BUY
$2.87 - $5.92 $6,314 - $13,024
2,200 New
2,200 $7,000
Q4 2018

Jan 31, 2019

SELL
$2.87 - $5.92 $6,314 - $13,024
-2,200 Closed
0 $0
Q3 2018

Dec 03, 2019

BUY
$4.5 - $7.6 $9,900 - $16,720
2,200 New
2,200 $13,000
Q3 2018

Nov 14, 2018

SELL
$4.5 - $7.6 $9,900 - $16,720
-2,200 Closed
0 $0
Q2 2018

Dec 03, 2019

BUY
$5.3 - $6.9 $11,660 - $15,180
2,200 New
2,200 $12,000
Q2 2018

Aug 03, 2018

SELL
$5.3 - $6.9 $11,660 - $15,180
-2,200 Closed
0 $0
Q1 2018

Dec 03, 2019

BUY
$3.65 - $7.95 $8,030 - $17,490
2,200 New
2,200 $13,000

Others Institutions Holding ADVM

About Adverum Biotechnologies, Inc.


  • Ticker ADVM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 99,333,600
  • Market Cap $471M
  • Description
  • Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...
More about ADVM
Track This Portfolio

Track Kbc Group Nv Portfolio

Follow Kbc Group Nv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.